Skip to content

Sharplink, Inc. SBET Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

Blackrock logo
BlackrockBLK

Other financials

Income statement

See full
Revenue$12.1M+1,525%
Gross profit$209.1K-25.4%
Operating income-$684.6M-73,829%
Net income-$685.6M-70,214%
EPS (diluted)-$3.25-76.6%

Balance sheet

See full
Cash & equivalents$16.9M+3,275%
Total debt$6.5M+213%
Total equity$1.7B+83,286%
Total assets$1.7B+62,686%

Cash flow

See full
Operating cash flow-$10.6M-1,971%
CapEx$3.7K+1,223%
Free cash flow-$9.1M-620%

Valuation

See full
Market cap$1B+61.1%
P/S25.5×-156×

Profitability

See full
Gross margin35.8%
Operating margin-3,600.5%-3,725pp
Net margin-3,604.6%-3,675pp
FCF margin-623%

Returns & leverage

See full
Return on equity-163.1%+447pp
Debt / equity0.7×
Current ratio3.3×0.0×

Where this comes from

Reported directly by Sharplink, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: Sharplink, Inc. ’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sharplink, Inc. 's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sharplink, Inc. 's indefinite-lived research and development assets?
Sharplink, Inc. (SBET) reported indefinite-lived research and development assets of $27K in Q4 2025.
What is the long-term trend for Sharplink, Inc. 's indefinite-lived research and development assets?
Over 3 years (2022 to 2025), Sharplink, Inc. 's indefinite-lived research and development assets has grown at a -3.9% compound annual growth rate (CAGR), from $30.43K to $27K.
What does indefinite-lived research and development assets mean?
These are acquired research and development projects that have not yet reached technological feasibility and are therefore not subject to amortization. They represent the value of innovation pipelines that are expected to contribute to future revenue growth once completed. Investors track these assets to evaluate the company's commitment to R&D and the potential for future product development.